PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gene therapy is halting cancer. Can it work against brain tumors?

2024-04-19
(Press-News.org) Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter new CAR-T guided by precision technology.  

A type of gene therapy called CAR-T that has extended survival for thousands of patients with leukemia and other blood cancers is being adapted at UC San Francisco to treat people with glioblastoma, the most common and deadly adult brain tumor. 
 
This new more powerful version of CAR-T employs a novel technology developed at UCSF called synthetic notch (synNotch) that both protects healthy tissue from damage and enables the treatment to work more effectively.  
 
UCSF opened enrollment this week for a clinical trial that is using the technology for the first time in people. A second trial, also at UCSF, is slated for 2025.  
 
 Approximately 12,000 Americans are diagnosed each year with glioblastoma. Patients survive on average for just 15 months after their diagnosis, and new treatments are urgently needed.  
 
“This project is a prime example of bench-to-bed translation within UCSF, representing the strengths in basic and clinical science, said Hideho Okada, MD, PhD, a physician-scientist and director of the UCSF Brain Tumor Immunotherapy Center. “We have a truly home-grown project here.” 
 
Okada has received up to $11 million for the first trial from the California Institute for Regenerative Medicine (CIRM), which funds stem cell and gene therapy research for incurable diseases and disorders through all stages of clinical trial development. 
 
Initial funding for the second trial is provided by the National Cancer Institute Specialized Programs of Research Excellence (NCI SPORE). 
 
“We hope that the treatment will prolong lives for patients with glioblastoma,” said Okada, who is a professor of neurosurgery at UCSF and a member of the Weill Institute for Neurosciences. “However, the primary goal of the current phase 1 study is to ensure safety and characterize any toxicities.”  
 
When tested in mice, Okada said the therapy provided a “robust and long-lasting result” that was more remarkable than anything he had encountered during 30 years of brain tumor research.  
 
A lasting therapy that is designed to reduce side effects 
 
The CIRM-funded trial will be led by principal investigator Jennifer Clarke, MD, MPH. It is open to patients with newly diagnosed glioblastoma, who have completed standard-of-care treatment. Tumors must have a mutation found in approximately 20% of glioblastomas, and that can be identified by the UCSF500 cancer gene panel test.  
 
The second study will be open to glioblastoma patients whether or not they have the mutation.  
 
CAR-T refers to chimeric antigen receptor T-cells, which are cancer-killing immune cells that have been extracted from the patient and genetically modified to recognize and destroy antigens that appear on the surface of cancer cells. These supercharged CAR-T cells are then infused back into the body to attack tumor cells.  
 
For many patients with leukemia and other blood cancers, CAR-T has demonstrated long-term remission, but the approach hasn’t worked against brain tumors. Glioblastoma cells are more diverse than blood cancer cells, and they can evade CAR-T. Many of the antigens made by the tumors are also found in healthy tissue, leaving them open to attack. 
 
To overcome these obstacles, Okada drew from the synNotch system developed by Wendell Lim, PhD, director of the UCSF Cell Design Institute and professor in the UCSF Department of Cellular and Molecular Pharmacology.  
 
The technology allowed scientists to program CAR-T cells to target specific antigens on tumor cells, without touching those found in healthy tissue. They also do not succumb to T-cell exhaustion, a common problem with CAR-T therapies, because they are more metabolically stable and use less energy to fight cancer longer. 
 
“We’ve created a system that is flexible and thorough and addresses the major concerns we’ve had about using CAR-T cells against solid tumors,” Lim said. “These cells act like computers: integrating multiple units of information and making complex decisions.” 

 

About UCSF: The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF's primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. UCSF School of Medicine also has a regional campus in Fresno. Learn more at https://ucsf.edu, or see our Fact Sheet.

###

 

Follow UCSF
ucsf.edu | Facebook.com/ucsf | YouTube.com/ucsf

 

About the California Institute for Regenerative Medicine (CIRM)
At CIRM, we never forget that we were created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency to succeed in that mission. To meet this challenge, our team of highly trained and experienced professionals actively partners with both academia and industry in a hands-on, entrepreneurial environment to fast track the development of today’s most promising stem cell technologies. With $5.5 billion in funding and more than 150 active stem cell programs in our portfolio, CIRM is one of the world’s largest institutions dedicated to helping people by bringing the future of cellular medicine closer to reality. For more information go to www.cirm.ca.gov

 

 

END


ELSE PRESS RELEASES FROM THIS DATE:

New copper-catalyzed C-H activation strategy from Scripps Research

2024-04-19
LA JOLLA, CA—Inspired by what human liver enzymes can do, Scripps Research chemists have developed a new set of copper-catalyzed organic synthesis reactions for building and modifying pharmaceuticals and other molecules. The new reactions are expected to be widely used in drug discovery and optimization, as well as in other chemistry-based industries. In their study, which initially published in an unedited version on March 28, 2024, in Nature, the chemists showed that their new methods can be used to perform two modifications—called dehydrogenations and lactonizations—on ...

New compound from blessed thistle promotes functional nerve regeneration

New compound from blessed thistle promotes functional nerve regeneration
2024-04-19
Blessed thistle (Cnicus benedictus) is a plant in the family Asteraceae and also grows in our climate. For centuries, it has been used as a medicinal herb as an extract or tea, e.g. to aid the digestive system. Researchers at the Center for Pharmacology of University Hospital Cologne and at the Faculty of Medicine of the University of Cologne have now found a completely novel use for Cnicin under the direction of Dr Philipp Gobrecht and Professor Dr Dietmar Fischer. Animal models as well as human cells have shown that Cnicin significantly accelerates axon (nerve fibres) growth. The study ...

Auburn’s McCrary Institute, ORNL to partner on first regional cybersecurity center to protect the nation’s electricity grid

Auburn’s McCrary Institute, ORNL to partner on first regional cybersecurity center to protect the nation’s electricity grid
2024-04-19
Auburn University’s McCrary Institute for Cyber and Critical Infrastructure Security was awarded a $10 million Department of Energy grant in partnership with Oak Ridge National Laboratory to create a pilot regional cybersecurity research and operations center to protect the electric power grid against cyberattacks.  The total value of the project is $12.5 million, with the additional $2.5 million coming from Auburn University and other strategic partners. The center, officially named the Southeast Region Cybersecurity Collaboration Center, or SERC3, will bring together experts from the private sector, academia and government to share information and generate innovative ...

New UNC-Chapel Hill study examines the increased adoption of they/them pronouns

2024-04-19
People are using “they/them” pronouns more often according to a new study by the University of North Carolina at Chapel Hill.  Led by UNC-Chapel Hill researcher Jennifer E. Arnold, Ph.D., the new research paper published on April 14 in Glossa Psycholinguistics provides the first evidence of how people use “they/them” when talking about a specific person in a spoken storytelling context.  “Within the last decade, people have started to use ‘they’ as a personal pronoun, often because they identify as nonbinary or gender nonconforming,” said Arnold, a professor ...

Groundbreaking study reveals potential diagnostic marker for multiple sclerosis years before symptom onset

2024-04-19
A new study published today in Nature Medicine unveils a significant breakthrough in the understanding and early detection of multiple sclerosis (MS). Researchers have identified a unique autoantibody signature present in approximately 10% of patients with MS years before the onset of clinical symptoms. Autoantibodies are basically antibodies that are supposed to fight off invaders but end up turning against one’s own body, causing problems like autoimmune diseases. Utilizing the U.S. Department ...

Annals of Internal Medicine presents breaking scientific news at ACP’s Internal Medicine Meeting 2024

2024-04-19
 Annals of Internal Medicine presents breaking scientific news at ACP’s Internal Medicine Meeting 2024   Authors discuss evidence-based research on obesity, antibiotic resistance, and type 2 diabetes   BOSTON April 19, 2024 – Today at ACP’s annual meeting, Internal Medicine Meeting 2024, Annals of Internal Medicine presented three breaking scientific research articles during a live scientific plenary session that featured the authors of those articles. The articles were published in ACP’s flagship journal concurrent with the live meeting presentation. During the session, New in Annals of Internal Medicine: Hear it First from the Authors, the authors ...

Scientists discover new way to extract cosmological information from galaxy surveys

Scientists discover new way to extract cosmological information from galaxy surveys
2024-04-19
Scientists at the National Astronomical Observatories of the Chinese Academy of Sciences (NAOC) and their international collaborators have recently developed a new method for efficiently extracting information from galaxy surveys. Their research results were published online in the latest issue of Communications Physics. Massive galaxy redshift surveys are powerful tools for probing the Universe in this era of precision cosmology. By observing a great number of spectra from distant galaxies, astronomers are able to create density fields of galaxies ...

Shoe technology reduces risk of diabetic foot ulcers

Shoe technology reduces risk of diabetic foot ulcers
2024-04-19
Researchers have developed a new shoe insole technology that helps reduce the risk of diabetic foot ulcers, a dangerous open sore that can lead to hospitalization and leg, foot or toe amputations. “The goal of this innovative insole technology is to mitigate the risk of diabetic foot ulcers by addressing one of their most significant causes: skin and soft tissue breakdown due to repetitive stress on the foot during walking,” said Muthu B.J. Wijesundara, principal research scientist at The University of Texas at Arlington Research Institute (UTARI). Affecting about 39 million people in the U.S., diabetes can damage the small blood vessels that supply blood to the nerves, ...

URI-led team finds direct evidence of ‘itinerant breeding’ in East Coast shorebird species

URI-led team finds direct evidence of ‘itinerant breeding’ in East Coast shorebird species
2024-04-19
KINGSTON, R.I. – April 17, 2024 – Migration and reproduction are two of the most demanding events in a bird’s annual cycle, so much so that the vast majority of migratory birds separate the two tasks into different times of the year. But a study by University of Rhode Island researchers has found direct evidence of a species – the American woodcock, a migratory shorebird from eastern and central North America – that overlaps periods of migration and reproduction, a rare breeding strategy known as “itinerant breeding.” Their work, backed by collaborators across the East Coast, was published today in the biological sciences journal Proceedings ...

Wayne State researcher aims to improve coding peer review practices

Wayne State researcher aims to improve coding peer review practices
2024-04-19
DETROIT — Amiangshu Bosu, Ph.D., assistant professor of computer science in the College of Engineering at Wayne State University, received a CAREER award from the National Science Foundation (NSF) to formulate better practices involving peer code review. Peer code review is a mandatory software verification practice among most open source and commercial software development organizations. In this practice, one or more peers inspect and approve a code change before integrating it into a project's repository. As developers spend significant effort daily ...

LAST 30 PRESS RELEASES:

Fatty liver in pregnancy may increase risk of preterm birth

World record for lithium-ion conductors

Researchers map 7,000-year-old genetic mutation that protects against HIV

KIST leads next-generation energy storage technology with development of supercapacitor that overcomes limitations

Urine, not water for efficient production of green hydrogen

Chip-scale polydimethylsiloxane acousto-optic phase modulator boosts higher-resolution plasmonic comb spectroscopy

Blood test for many cancers could potentially thwart progression to late stage in up to half of cases

Women non-smokers still around 50% more likely than men to develop COPD

AI tool uses face photos to estimate biological age and predict cancer outcomes

North Korea’s illegal wildlife trade threatens endangered species

Health care workers, firefighters have increased PFAS levels, study finds

Turning light into usable energy

Important step towards improving diagnosis and treatment of brain metastases

Maternal cardiometabolic health during pregnancy associated with higher blood pressure in children, NIH study finds

Mercury levels in the atmosphere have decreased throughout the 21st century

This soft robot “thinks” with its legs

Biologists identify targets for new pancreatic cancer treatments

Simple tweaks to a gene underlie the stench of rotten-smelling flowers

Simple, effective interventions reduce emissions from Bangladesh’s informal brick kilns

Ultrasound-guided 3D bioprinting enables deep-tissue implant fabrication in vivo

Soft limbs of flexible tubes and air enable dynamic, autonomous robotic locomotion

Researchers develop practical solution to reduce emissions and improve air quality from brick manufacturing in Bangladesh

Durham University scientists solve 500-million-year fossil mystery

Red alert for our closest relatives

3D printing in vivo using sound

Global Virus Network meeting unites Caribbean and Latin America to tackle emerging viral threats

MD Anderson Research Highlights for May 8, 2025

Study of Türkiye gold mine landslide highlights need for future monitoring

Researchers find new defense against hard-to-treat plant diseases

Characterization of research grant terminations at the National Institutes of Health

[Press-News.org] Gene therapy is halting cancer. Can it work against brain tumors?